The Discounted Cash Flow (DCF) valuation of Spero Therapeutics Inc (SPRO) is 5.55 USD. With the latest stock price at 1.15 USD, the upside of Spero Therapeutics Inc based on DCF is 382.6%.
| Range | Selected | |
| WACC / Discount Rate | 7.3% - 9.5% | 8.4% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 4.92 - 6.49 | 5.55 |
| Upside | 327.6% - 464.7% | 382.6% |